Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial)
Mazer, C David, Siadati-Fini, Niloufar, Boehm, Johannes, Wirth, Felix, Myjavec, Andrej, Brown, Craig D, Koyner, Jay L, Boening, Andreas, Engelman, Daniel T, Larsson, Tobias E, Renfurm, Ronny, de Varennes, Benoit, Noiseux, Nicolas, Thielmann, Matthias, Lamy, Andre, Laflamme, Maxime, von Groote, Thilo, Ronco, Claudio, Zarbock, Alexander
Published in BMJ open (06.04.2023)
Published in BMJ open (06.04.2023)
Get full text
Journal Article